These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29752185)

  • 1. Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery.
    Shi Y; Mader M
    Bioorg Med Chem Lett; 2018 Jun; 28(11):1981-1991. PubMed ID: 29752185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.
    Saraswati AP; Ali Hussaini SM; Krishna NH; Babu BN; Kamal A
    Eur J Med Chem; 2018 Jan; 144():843-858. PubMed ID: 29306837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK inhibitors as anti-inflammatory and neuroprotective agents.
    Graczyk PP
    Future Med Chem; 2013 Apr; 5(5):539-51. PubMed ID: 23573972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models.
    Roy SM; Grum-Tokars VL; Schavocky JP; Saeed F; Staniszewski A; Teich AF; Arancio O; Bachstetter AD; Webster SJ; Van Eldik LJ; Minasov G; Anderson WF; Pelletier JC; Watterson DM
    ACS Chem Neurosci; 2015 Apr; 6(4):666-80. PubMed ID: 25676389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery.
    Zagorska A; Partyka A; Bucki A; Gawalskax A; Czopek A; Pawlowski M
    Curr Med Chem; 2018; 25(29):3455-3481. PubMed ID: 29521210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
    Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
    J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents.
    Bos PH; Lowry ER; Costa J; Thams S; Garcia-Diaz A; Zask A; Wichterle H; Stockwell BR
    Cell Chem Biol; 2019 Dec; 26(12):1703-1715.e37. PubMed ID: 31676236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.
    Li S; Wei D; Mao Z; Chen L; Yan X; Li Y; Dong S; Wang D
    Bioorg Chem; 2017 Aug; 73():63-75. PubMed ID: 28618343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and kinase inhibitory activity of novel substituted indigoids.
    Beauchard A; Laborie H; Rouillard H; Lozach O; Ferandin Y; Le Guével R; Guguen-Guillouzo C; Meijer L; Besson T; Thiéry V
    Bioorg Med Chem; 2009 Sep; 17(17):6257-63. PubMed ID: 19665384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions.
    Grieco I; Bassani D; Trevisan L; Salmaso V; Cescon E; Prencipe F; Da Ros T; Martinez-Gonzalez L; Martinez A; Spalluto G; Moro S; Federico S
    Bioorg Chem; 2024 Oct; 151():107659. PubMed ID: 39059072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3.
    Sciú ML; Sebastián-Pérez V; Martinez-Gonzalez L; Benitez R; Perez DI; Pérez C; Campillo NE; Martinez A; Moyano EL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):87-96. PubMed ID: 30362380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase targets in CNS drug discovery.
    Gunosewoyo H; Yu L; Munoz L; Kassiou M
    Future Med Chem; 2017 Mar; 9(3):303-314. PubMed ID: 28176536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models.
    Patel S; Cohen F; Dean BJ; De La Torre K; Deshmukh G; Estrada AA; Ghosh AS; Gibbons P; Gustafson A; Huestis MP; Le Pichon CE; Lin H; Liu W; Liu X; Liu Y; Ly CQ; Lyssikatos JP; Ma C; Scearce-Levie K; Shin YG; Solanoy H; Stark KL; Wang J; Wang B; Zhao X; Lewcock JW; Siu M
    J Med Chem; 2015 Jan; 58(1):401-18. PubMed ID: 25341110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12).
    Patel S; Harris SF; Gibbons P; Deshmukh G; Gustafson A; Kellar T; Lin H; Liu X; Liu Y; Liu Y; Ma C; Scearce-Levie K; Ghosh AS; Shin YG; Solanoy H; Wang J; Wang B; Yin J; Siu M; Lewcock JW
    J Med Chem; 2015 Oct; 58(20):8182-99. PubMed ID: 26431428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration.
    Wang L; Ankati H; Akubathini SK; Balderamos M; Storey CA; Patel AV; Price V; Kretzschmar D; Biehl ER; D'Mello SR
    J Neurosci Res; 2010 Jul; 88(9):1970-84. PubMed ID: 20143421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases.
    Krahn AI; Wells C; Drewry DH; Beitel LK; Durcan TM; Axtman AD
    ACS Chem Neurosci; 2020 Jul; 11(13):1871-1886. PubMed ID: 32464049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
    Brogi S; Ramunno A; Savi L; Chemi G; Alfano G; Pecorelli A; Pambianchi E; Galatello P; Compagnoni G; Focher F; Biamonti G; Valacchi G; Butini S; Gemma S; Campiani G; Brindisi M
    Eur J Med Chem; 2017 Sep; 138():438-457. PubMed ID: 28689095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated molecules in the diagnosis and treatment of neurodegenerative diseases.
    Gaye B; Adejare A
    Future Med Chem; 2009 Aug; 1(5):821-33. PubMed ID: 21426082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.